TREAT COVID-19 WITH PAXLOVID
SAVE ON PAXLOVIDEligibility required
Who can take PAXLOVID?
As much as we all wish
PAXLOVID is an oral prescription medication available under an EUA that can treat children 12 years and older weighing at least 88 pounds who:
have mild-to-moderate COVID-19, and
have had symptoms for 5 days or fewer, and
have a high-risk factor for progression to severe
PAXLOVID is not authorized for use as pre-exposure or post-exposure treatment for prevention of
Some of the most common risk factors for progression to severe
COVID-19 include:
-
Certain health conditions and diseases, such as heart disease and diabetes
- Obesity (≥95th percentile in children)
- Mental health conditions
- Certain lifestyle factors
- Physical, mental, and developmental disabilities
Actor portrayals of high-risk patients ages 12+
Not sure what puts
people at at high risk?
Actor portrayals of high-risk patients ages 12+
Some of the most common risk factors for progression to severe
COVID-19 include:
-
Certain health conditions and diseases, such as heart disease and diabetes
- Obesity (≥95th percentile in children)
- Mental health conditions
- Certain lifestyle factors
- Physical, mental, and developmental disabilities
Despite the
†Other administrative fees may apply. The U.S. Government has purchased PAXLOVID from Pfizer and is continuing to make it available at no charge, regardless of insurance.
Despite the
†Other administrative fees may apply. The U.S. Government has purchased PAXLOVID from Pfizer and is continuing to make it available at no charge, regardless of insurance.
A trial compared the risk of COVID-19–related hospitalization or death in adults treated with PAXLOVID vs placebo.
It’s important to understand the risks and possible side effects of PAXLOVID before starting treatment.
Be prepared for
It is important to take action for patients who are at high risk of progression to severe
Be prepared for
It is important to take action for patients who are at high risk of progression to severe
How to verify tablets are authentic
PAXLOVID must be prescribed by a licensed healthcare professional and supplied by a government-approved pharmacy or medical facility.
Authentic PAXLOVID, from Pfizer Inc., will include the Pfizer name on the label and will be packaged in several aluminum push-through blister cards. Individual doses are not for sale. PAXLOVID will be packaged in a carton. The carton has a colorless, glossy coating that contains a repeated pattern of the Pfizer name and logo all over, and these repeating features are seen in a contrasting matte finish.
PAXLOVID consists of tablets for a 5-day oral treatment regimen, with morning and evening doses.
NOTE: Patients with moderate kidney disease may receive a carton with daily blister cards that have been modified to ensure the correct dose is given.
To help determine whether the tablets are authentic, look for specific text on each side of the tablets
| Tablet | Embossed Text |
|---|---|
| nirmatrelvir | Front: 3CL | Back: PFE |
| ritonavir, manufactured by AbbVie | Front: NK | Back: No text |
Pfizer is committed to patient safety and ensuring that people have accurate information about PAXLOVID, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate PAXLOVID to protect patients from products that might be dangerous and lead to serious and life-threatening harm.
If you or the patient suspect the product that you have received may be counterfeit, contact us at
For packaging options and information, see the Patient PAXLOVID Packaging Flashcard.
For packaging options and information, see the Patient PAXLOVID Packaging Flashcard.
For more information
Contact one of the following groups:
For medical information visit www.pfizermedicalinformation.com or
For general product inquiries
